Salicylate increased manganese-superoxide dismutase (Mn-SOD) gene expression, but decreased catalase (CAT) gene expression in the cochlea and various brain regions of mice with tinnitus. Spirulinaplatensis water extract reduced salicylate-induced overexpression of the Mn-SOD gene, but increased salicylate-induced downregulation of the CAT gene. With the exception of significantly increased SOD activity in the brainstem and inferior colliculus of the Spirulina group, SOD and CAT enzyme activities did not differ among the three groups. The tinnitus group had higher malondialdehyde (MDA) levels than the control group in the temporal and the frontal lobes. S.platensis water extract reduced salicylate-induced elevations of MDA levels in many brain areas. We proposed that altered expression of antioxidant genes may reflect states of oxidative stress associated with tinnitus.

Keywords:
Tinnitus, Salicylate, Antioxidant gene expression, Malondialdehyde, Spirulina platensis
1.
Bauer CA, Brozoski TJ, Holder TM, Caspary DM: Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear Res 2000;147:175-182.
2.
Bhat VB, Madyastha KM: C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro. Biochem Biophys Res Commun 2000;275:20-25.
3.
Chamorro G, Salazar M, Araújo KG, dos Santos CP, Ceballos G, Castillo LF: Update on the pharmacology of Spirulina (Arthrospira), an unconventional food (in Spanish). Arch Latinoam Nutr 2002;52:232-240.
4.
Chen JC, Liu KS, Yang TJ, Hwang JH, Chan YC, Lee IT: Spirulina and C-phycocyanin reduce cytotoxicity and inflammation-related genes expression of microglial cells. Nutr Neurosci 2012, DOI: 10.1179/1476830512Y.0000000020.
5.
Choi BH: Oxygen, antioxidants and brain dysfunction. Yonsei Med J 1993;34:1-10.
6.
Coling DE, Yu KC, Somand D, Satar B, Bai U, Huang TT, Seidman MD, Epstein CJ, Mhatre AN, Lalwani AK: Effect of SOD1 overexpression on age- and noise-related hearing loss. Free Radic Biol Med 2003;34:873-880.
7.
Evans EF, Borerwe TA: Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. Br J Audiol 1982;16:101-108.
8.
Guitton MJ, Caston J, Ruel J, Johnson RM, Pujol R, Puel JL: Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003;23:3944-3952.
9.
Hwang JH, Chen JC, Chan YC: Effects of C-phycocyanin and Spirulina on salicylate-induced tinnitus, expression of NMDA receptor and inflammatory genes. PLoS One 2013;8:e58215.
10.
Hwang JH, Chen JC, Hsu CJ, Yang WS, Liu TC: Plasma reactive oxygen species levels are correlated with severity of age-related hearing impairment in humans. Neurobiol Aging 2012;33:1920-1926.
11.
Hwang JH, Chen JC, Yang SY, Wang MF, Chan YC: Expression of tumor necrosis factor-α and interleukin-1β genes in the cochlea and inferior colliculus in salicylate-induced tinnitus. J Neuroinflammation 2011a;8:30.
12.
Hwang JH, Chen JC, Yang SY, Wang MF, Liu TC, Chan YC: Expression of COX-2 and NMDA receptor genes at the cochlea and midbrain in salicylate-induced tinnitus. Laryngoscope 2011b;121:361-364.
13.
Hwang JH, Lee IT, Jeng KC, Wang MF, Hou RC, Wu SM, Chan YC: Spirulina prevents memory dysfunction, reduces oxidative stress damage and augments antioxidant activity in senescence-accelerated mice. J Nutr Sci Vitaminol (Tokyo) 2011c;57:186-191.
14.
Jia MH, Qin ZB: Expression of c-fos and NR2A in auditory cortex of rats experienced tinnitus (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006;41:451-454.
15.
Keithley EM, Canto C, Zheng QY, Wang X, Fischel-Ghodsian N, Johnson KR: Cu/Zn superoxide dismutase and age-related hearing loss. Hear Res 2005;209:76-85.
16.
Liu J, Mori A: Age-associated changes in superoxide dismutase activity, thiobarbituric acid reactivity and reduced glutathione level in the brain and liver in senescence accelerated mice (SAM): a comparison with ddY mice. Mech Ageing Dev 1993;71:23-30.
17.
McCarty MF, Barroso-Aranda J, Contreras F: Oral phycocyanobilin may diminish the pathogenicity of activated brain microglia in neurodegenerative disorders. Med Hypotheses 2010;74:601605.
18.
Puel JL, Guitton MJ: Salicylate-induced tinnitus: molecular mechanisms and modulation by anxiety. Prog Brain Res 2007;166:141-146.
19.
Romay C, Ledón N, González R: Phycocyanin extract reduces leukotriene B4 levels in arachidonic acid-induced mouse-ear inflammation test. J Pharm Pharmacol 1999;51:641-642.
20.
Seidman MD: Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope 2000;110:727-738.
21.
Suge R, Shimazu T, Hasegawa H, Inoue I, Hayashibe H, Nagasaka H, Araki N, Katayama S, Nomura M, Watanabe S: Cerebral antioxidant enzyme increase associated with learning deficit in type 2 diabetes rats. Brain Res 2012;1481:97-106.
22.
Wallhäusser-Franke E, Cuautle-Heck B, Wenz G, Langner G, Mahlke C: Scopolamine attenuates tinnitus-related plasticity in the auditory cortex. Neuroreport 2006;17:1487-1491.
23.
Wang HT, Luo B, Zhou KQ, Xu TL, Chen L: Sodium salicylate reduces inhibitory postsynaptic currents in neurons of rat auditory cortex. Hear Res 2006;215:77-83.
24.
Weber C, Arck P, Mazurek B, Klapp BF: Impact of a relaxation training on psychometric and immunologic parameters in tinnitus sufferers. J Psychosom Res 2002;52:29-33.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.